Phase 4 N=93 Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young Children
Attention Deficit Disorder With Hyperactivity
Primary: Change in ADHD-IV Rating Scale Total Score — -13.2; -5.8 units on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=72 Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study
Diabetic Macular Edema
Primary: Proportion of Subjects Who Gain Two or More Lines in Best Corrected Visual Acuity(BCVA) Score in the Study Eye Compared With Baseline. — 3; 18 participants
Phase 4 N=162 A Study to Compare Safety and Efficacy of Tramadol Hydrochloride/Acetaminophen With Gabapentin in Participants With Diabetic Neuropathy
Diabetic Neuropathy
Primary: Change From Baseline in Pain Intensity Score at Day 43 — 6.65; 6.30; 3.15; 2.76 Units on a scale — p=0.2143
Phase 4 N=42 Evaluate Recovery of Testosterone for Patients Using Eligard
Prostate Cancer
Primary: Serum Testosterone Recovery — 6 Months
Phase 4 N=270 Trichomonas Vaginalis Recurrence Among HIV+ Women
Trichomonas Infections · HIV Infections
Primary: TV Culture Positive Result — 11; 21 participants — p=.045
Phase 4 N=237 An Efficacy and Safety Study of Fentanyl Transdermal Patch in Filipino Participants With Osteoarthritis and Chronic Low Back Pain
Osteoarthritis · Low Back Pain
Primary: Change From Baseline in Brief Pain Inventory (BPI) Severity Score at Day 30 — 7.20; 3.83; 5.59; 5.49 Units on a scale
Phase 4 N=12 A Comparison of the Addiction Liability of Hydrocodone and Sustained Release Morphine
Chronic Pain
Primary: 3 Scores on the Addiction Research Center Inventory (ARCI) — 7.6; 5.4; 5.2; 3.3 scores on a scale
Phase 4 N=12 Effect of Parathyroid Hormone (PTH) and Weight-Bearing on Bone in Spinal Cord Injury (SCI)
Osteoporosis · Bone Loss · Spinal Cord Injury
Primary: BMD at Left Total Hip — 0.02 % change in BMD (gm/cm2) from baseline
Phase 4 N=888 Pharmacogenomic Evaluation of Antihypertensive Responses
Hypertension
Primary: Blood Pressure Response (Delta BP (After 18 Weeks of Medication - Baseline)). — -12.06; -13.33 mmHg
Phase 4 N=20 Visibility of Site Marking for Surgical Time Out With Two Different Skin Preparation Solutions
Arthroplasty, Replacement, Hip
Primary: Identification of the Random Initials by the Reviewing Orthopaedic Surgeons — 209; 296 number of correctly identified initals
Phase 4 N=49 Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol
Glaucoma
Primary: Mean Intraocular Pressure (IOP) Change at the Final Visit From Baseline (Prior Beta-blocker Monotherapy) — -5.0 millimeters mercury (mmHg)
Phase 4 N=70 Safety and Efficacy Study of Altabax Ointment in the Treatment of Secondarily Infected Atopic Dermatitis
Atopic Dermatitis · Secondary Infection
Primary: Bacteriological Culture — 13; 3; 16; 5 participants
Phase 4 N=34 Comparison of the Effect of Vytorin 10/80 Tablet Split Into 4 and Simvastatin 20 Milligrams on Low-density Lipoprotein (LDL) Cholesterol
Hypercholesterolemia
Primary: LDL Cholesterol — -44.7; -27.1 % change in LDL cholesterol
Phase 4 N=35 Efficacy and Safety Study of Transdermal Therapeutic System (TTS) Fentanyl in Participants With Osteoarthritis Knee Pain
Osteoarthritis, Knee
Primary: Change From Baseline in Western Ontario McMaster Universities Osteoarthritis Index (WOMAC) Score at Day 30 — -22.2; -21.5; -29.5; -73.2 Millimeter (mm)
Phase 4 N=80 An Efficacy Study of Combination of Tramadol and Acetaminophen Tablets in the Treatment of Participants With Fibromyalgia Pain
Pain · Fibromyalgia
Primary: Pain Visual Analog Scale Score at Day 14 — 53.0 Millimeter (mm)